Reliability of preoperative evaluation of prognostic factors in endometrial carcinoma

International Journal of Gynecology and Obstetrics

Volumn 59, Issue 1, 1997, Pages 35-39

  Valsecchi, L ^a   Mangili, G ^a   Frigerio, L ^a   Spagnolo, D L ^a   De Sanctis, L ^b   Ferrari, A ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Endometrial carcinoma; Preoperative staging; Prognostic factors; Transvaginal sonography; Tumor ploidy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; FEMALE; FLOW CYTOMETRY; HIGH RISK PATIENT; HUMAN; MYOMETRIUM; PLOIDY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; TRANSVAGINAL ECHOGRAPHY;

EID: 0030763408     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(97)00132-X     Document Type: Article

References (17)

1. Morrow CP, Bundy CN, Kurman RG et al. Relationship between surgical-pathological risk factors and outcome in clinical Stage I and II carcinoma of the endometrium: a gynecological oncology group study. Gynecol Oncol 1991;40:55-65.
2. Britton LC, Wilson TO, Gaffey TA, Lieber MM, Wieand HS, Podratz KC. Flow cytometric DNA analysis of Stage I endometrial carcinoma. Gynecol Oncol 1989;34:317-322.
3. Mikuta JJ. International Federation of Gynecologic and Obstetric staging of endometrial cancer. Cancer 1993;71:1460-1463.
4. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JF, Heller PB. Surgical pathological spread patterns of endometrial cancer (a Gynecologic Oncology Group Study). Cancer 1987;60:2035-2041.
5. Ikeda M, Watanabe Y, Nanjoh T et al. Evaluation of DNA ploidy in endometrial cancer. Gynecol Oncol 1993;50:25-29.
6. Mangioni C, De Palo G, Marubini E, Del Vecchio M. Surgical pathological staging in apparent Stage I endometrial carcinoma. Gynecol Cancer 1993;3:373-384.
7. Del Maschio A, Vanzulli A, Sironi S, Spagnolo D, Belloni C, Garancini P, Taccagni GM. Estimating the depth of myometrial involvement by endometrial carcinoma: efficacy of transvaginal sonography vs MR imaging. Am J Roentgenol 1993;160:522-538.
8. Gordon AN, Fleisher AC, Reed GW. Depth of myometrial invasion in endometrial cancer: preoperative assessment by transvaginal ultrasonography. Gynecol Oncol 1990;39:321-327.
9. Childers JM, Brzechffa PR, Hatch KD, Surwit EA. Laparoscopically assisted surgical staging (LASS) of endometrial cancer. Gynecol Oncol 1993;51:33-38.
10. Scambia G, Gadducci A, Benedetti Panici P et al. Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma. Gynecol Oncol 1994;54: 294-297.
11. Patsner B, Mann WJ, Cohen H, Lash M. Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinoma. Am J Obstet Gynecol 1988;58:399-402.
12. Hricak H, Stern JL, Fisher MR, Shapeero LG, Winkler MI, Lacey CG. Endometrial carcinoma staging by MR imaging. Radiology 1987;62:297-305.
13. Doering DL, Barnhill DR, Weiuser EB et al. Intraoperative evaluation of depth of myometrial invasion in Stage I endometrial adenocarcinoma. Obstet Gynecol 1989;74:930-935.
14. Walsh JW, Goplerud DR. Computed tomography of primary, persistent and recurrent endometrial malignancy. Am J Roentgenol 1982;139:1149-1154.
15. Creasman WT, Morrow CP, Bundy BM et al. Surgical pathologic spread pattern in endometrial cancer. Cancer 1987;60:2035-2041.
16. Bloss JD, Berman ML, Leslie PB, Buller RE. Use of vaginal hysterectomy for the management of Stage I endometrial cancer in medically compromised patients. Gynecol Oncol 1991;40:74-77.
17. Candiani GB, Belloni C, Maggi R, Colombo G, Frigoli A, Carinelli S. Evaluation of different surgical approaches in the treatment of endometrial cancer at Figo Stage I. Gynecol Oncol 1990;37:6-8.